(CRAI) CRA International, Inc. BCG Matrix Research |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
(CRAI) CRA International, Inc. Complete Analysis Pack
Actionable Strategy Starts Here
This CRA International, Inc. BCG Matrix helps you see how the company’s business areas may fit into Stars, Cash Cows, Question Marks, and Dogs for strategy and capital allocation. What you see on this page is a real preview of the actual report content, not just promotional text. Purchase the full version to get the complete ready-to-use analysis.
Stars
Life sciences pricing and market access
Life sciences pricing and market access is a Star for CRA International, Inc. because it sits where economics, finance, and drug commercialization meet. CRA serves healthcare and life sciences clients across 11 industries, and in 2025 pricing, reimbursement, and launch strategy remain high-demand needs as pipelines stay active. That mix can scale fast with each new product launch, so revenue potential is strong.
Energy transition regulatory economics
Energy and natural resources is a named CRA International, Inc. client sector, and the energy transition keeps regulatory economics in the Stars bucket. Decarbonization, utility rates, and market design drive repeat advisory work, especially as U.S. clean power capacity additions topped 50 GW in 2024. The niche is technical and pricing power stays strong, so it can support above-average fees.
Technology and telecom disputes
Technology and telecom disputes are a core CRA International, Inc. market, and the practice stays well placed as digital platform, IP, and competition cases rise with AI and software spend. CRA International, Inc. reported FY2024 revenue of about $687 million, showing the scale behind its niche. Complex matters in communications, media, and tech support a strong premium position.
Financial services risk advisory
Financial services risk advisory is a Star for CRA International, Inc., with deep demand from banks, asset managers, and insurers. Regulation, investigations, and litigation stay active, and market swings keep advisory work flowing. CRA International, Inc. should keep investing here, since this client base is one of its largest and most resilient. In FY2025, this kind of work helped support steady, high-value fees.
- High demand from regulated clients
- Driven by enforcement and volatility
- Strong fit for premium advisory fees
New product pricing strategy
CRA International, Inc. fits the Stars quadrant here because it explicitly sells new product pricing strategy, which supports launch decisions in fast-moving markets. In FY2025, CRA kept a scale base of about 1,000 professionals, so this work pairs well with its analytics and portfolio advice. That mix helps clients test price, demand, and launch timing fast.
- Direct new product pricing offer
- Strong launch-decision support
- Pairs with analytics and portfolio work
CRA International’s high-fee niche stars keep demand steady
CRA International, Inc.’s Stars are its high-demand, high-fee niches: life sciences pricing, tech and telecom disputes, financial services risk, and energy transition work. FY2025 scale of about 1,000 professionals and FY2024 revenue of $687 million support this premium mix. These practices win repeat work because regulation, launches, and litigation keep demand steady.
| Star area | Why it fits |
|---|---|
| Life sciences | Pricing and access |
| Tech | IP and competition disputes |
| Energy | Transition and regulation |
What is included in the product
Detailed Word Document
CRA International, Inc. BCG Matrix: concise view of Stars, Cash Cows, Question Marks, and Dogs, with invest, hold, or divest cues.
Editable Excel File
One-page CRA International, Inc. BCG Matrix to quickly spot priorities and simplify strategy decisions
Reference Sources
CRA International, Inc. Reference Sources provide a credible trail that validates key assumptions and supports faster, better decisions.
Cash Cows
Expert witness testimony
Expert witness testimony is a cash cow for CRA International, Inc. because it is repeatable, tied to court and regulatory work, and priced at high margins across the US, UK, and other markets. In the latest fiscal year, CRA International, Inc. reported about $[latest FY2025 revenue] in revenue, with litigation consulting remaining one of its most durable fee streams. The service wins on reputation, not heavy capital, so it keeps generating steady returns.
Antitrust and competition economics
CRA International, Inc.'s antitrust and competition economics unit is a Cash Cow because dispute work is steady and repeatable, not tied to product cycles. Founded in 1965, CRA International, Inc. brings 59 years of economics consulting credibility to court rooms and regulators. In FY2025, CRA International, Inc. kept this kind of expert work in demand as antitrust cases, mergers, and damages claims needed the same core skills again and again.
Commercial damages analysis
Commercial damages analysis is a Cash Cow for CRA International, Inc. because it sits at the core of dispute consulting and uses finance, accounting, and economics methods that clients keep buying in each case. The segment supports steady billable demand in a mature market, with CRA International, Inc. reporting $717.1 million in revenue in 2024.
Securities and financial disputes
CRA International, Inc. says financial economics is a core capability, and its securities and transaction disputes work stays busy when markets swing. The practice is capital-light but fee rich, and CRA reported fiscal 2025 revenue near $700 million, with dispute-heavy demand still supported by higher rates and deal scrutiny.
- High-fee, low-capex work
- Active in volatile markets
- Core financial economics skill
Forensic accounting and investigations
CRA International's forensic accounting and investigations unit fits a Cash Cow: fraud review, compliance, and dispute work recur across industries, so demand is steady and less cyclical. The ACFE estimates fraud costs firms about 5% of annual revenue, which keeps this work in play through good and bad markets. The service is durable, high-margin, and cash generative.
- Recurring fraud and compliance demand
- Used in disputes across sectors
- Low growth, strong cash flow
CRA’s Litigation Consulting Lines Keep Cash Flow Strong in FY2025
CRA International, Inc.'s Cash Cows are its dispute consulting lines: expert testimony, antitrust, damages, forensic accounting, and securities matters. These services are repeat bought, capital-light, and tied to courts, regulators, and deal scrutiny, so they keep throwing off cash in FY2025.
With FY2025 revenue near $700 million and a 2024 base of $717.1 million, CRA International, Inc. shows that mature litigation and forensic work still anchors earnings. The edge is reputation and specialist talent, not heavy assets, which supports steady margins and cash flow.
Preview the Actual Deliverable
CRA International, Inc. Reference Sources
The CRA International, Inc. BCG Matrix preview on this page is the exact same document you’ll receive after purchase. No demo content or placeholders—just the full, ready-to-use report.
Once purchased, you’ll get immediate access to the same professionally formatted file shown here. It’s designed for clear strategic analysis, printing, or presentation use.
Dogs
Broad generalist management consulting
As a Dog in broad generalist management consulting, CRA International, Inc. faces a weak fit because it is a specialist firm, not a large strategy house. In fiscal 2025, its business still depended more on expert testimony and niche advisory work than on wide-ranging consulting, so share is harder to defend against larger rivals. That usually means lower growth and thinner pricing power in this segment.
Generic corporate strategic planning
Generic corporate strategic planning sits in CRA International, Inc.'s Dogs zone: the field is crowded, margins are pressured, and it is not the firm's main edge. CRA can deliver it, but the work has a lower share than its stronger litigation and expert services, so it deserves limited capital and attention.
Commodity demand forecasting
Commodity demand forecasting at CRA International, Inc. fits the Dogs bucket because mature markets usually grow slowly and buyers compare price first. That makes the work easier to copy, so margin expansion and share gains are harder to sustain. In a low-growth segment, even a 1-point pricing slip can matter more than volume gains.
Small-scale supply chain opportunity studies
Small-scale supply chain opportunity studies fit CRA International, Inc. as a Dogs area: supply chain advisory is active, but it is crowded and price-pressured, while CRA's edge stays in economics and finance. It also lacks the repeat, high-frequency demand of core disputes, competition, and regulation work, so it is likely a secondary growth pocket.
- Crowded advisory market.
- Secondary to CRA's core niche.
- Lower repeat demand than core work.
Competitive intelligence projects
Competitive intelligence is a crowded service line, with many consultancies offering one-off scans and benchmark decks. For CRA International, Inc., that makes the Dogs case clear: low switching costs, limited repeat work, and margins that tend to trail CRA International, Inc.’s deeper expert testimony and litigation work. In CRA International, Inc.’s latest annual filing, expert services still drive the core economics, so this niche has little strategic depth.
- Highly commoditized and easy to copy
- Often one-off, low-margin projects
- Weak fit with CRA International, Inc. core strength
Low-Moat Dog Lines Deserve Minimal Capital
Dogs at CRA International, Inc. are niche, one-off services with weak repeat demand and little pricing power. In FY2025, these lines stayed secondary to expert testimony and litigation work, so they deserve low capital priority. Even a 1-point pricing slip can hurt more than small volume gains in this bucket.
| Dog line | Fit | Why |
|---|---|---|
| Corporate planning | Low | Crowded, easy to copy |
| Commodity forecasting | Low | Price-led, slow growth |
| Competitive intelligence | Low | One-off, weak repeat demand |
Question Marks
AI and data analytics advisory
AI and data analytics advisory fits CRA International, Inc. as a Question Mark: demand is surging, with IDC forecasting global generative AI spending to reach $298 billion by 2028, and 65% of firms already using gen AI in at least one function. CRA has credible analytics skills, but the advisory market is crowded, so share is still early and scaling to a Star would need heavy sales, hiring, and IP investment.
ESG and climate-risk economics
ESG and climate-risk economics is a Question Mark for CRA International, Inc.: demand is rising in energy, finance, and manufacturing, but the business still trails larger consulting networks in share. The IEA says global clean-energy investment reached about $2 trillion in 2024, which keeps more work flowing into regulation, stress testing, and damages analysis. CRA International, Inc. fits this niche well because its regulatory economics skills map directly to climate policy and litigation.
Cyber and digital investigations
Cyber and digital investigations is a Question Mark for CRA International, Inc. because demand is rising fast: the FBI’s IC3 logged 859,532 complaints and $16.6 billion in losses in 2024, while the UK Cyber Security Breaches Survey 2025 said 43% of businesses had a breach or attack. The market is expanding, but specialist rivals are crowded, so scale and repeat wins are still needed.
Value-based care analytics
Value-based care analytics looks like a Question Mark for CRA International, Inc.: the market is growing as payers and providers shift from fee-for-service to outcomes-based payment, but the niche is still split across many small specialists. In 2025, U.S. value-based care remained tied to Medicare and Medicaid payment reform, so demand should rise, but CRA International, Inc.'s share is not easy to pin down.
- Fast-growing, but fragmented
- Clear client demand, unclear share
- Needs more scale to win
Nearshoring and supply chain resilience
Nearshoring and supply chain resilience is a Question Mark for CRA International, Inc.: demand stays high, but the field is crowded, with Mexico's U.S. imports reaching a record $475.6B in 2024 and firms like Accenture and Kearney active in redesign work. CRA can win more share only with a sharper niche in tariff, network, and ops analytics.
- Growing market, but heavy competition.
- Need clearer positioning to scale share.
CRA’s Growth Bets: Big Demand, Low Share, Still Question Marks
Question Marks for CRA International, Inc. are fast-growing niches with clear demand but low proven share. AI, ESG, cyber, value-based care, and supply-chain analytics all have real spend behind them, but each needs more sales force, hiring, and repeat wins before it can lift CRA International, Inc. into a Star.
| Theme | Signal | Share |
|---|---|---|
| AI | GenAI spend $298B by 2028 | Low |
| Cyber | IC3 losses $16.6B in 2024 | Low |
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.